机构:[1]Department of Pharmacy, Guangzhou General Hospital of Guangzhou Military Command,Guangzhou, Guangdong 510010[2]Department of Oncology, Guangdong No. 2 Provincial People's Hospital, Guangzhou,Guangdong 510317[3]Department of Pharmacy, The Second People's Hospital of Foshan, Foshan, Guangdong 528000[4]Department of Urology, Southern Hospital of Southern Medical University, Guangzhou, Guangdong 510515[5]School of Traditional Chinese Medicine, Southern Medical University, Guangzhou, Guangdong 510515, P.R. China
Yifuning is a traditional Chinese medicine recipe that has been used for many years in China for its effects on treating climacteric syndrome in women. The present study aimed to demonstrate the effects and underlying molecular mechanism of Yifuning on the ovaries of aging rats. Selected aging rats were administered different doses of Yifuning (1.0 or 2.0 g/kg by lavage), and after 6 weeks the rats were sacrificed. The activit of indicators of oxidative stress in the serum were measured. The expression levels of 8-oxo-2'-deoxyguanosine (8-OHDG) and p53 in the ovaries were examined using immunohistochemistry. The expression levels of the corresponding genes and proteins were detected by reverse transcription‑quantitative polymerase chain reaction and western blotting analyses, respectively. The results indicated that Yifuning significantly prevented ovarian failure, as indicated by improvements in estrous cycling, reproductive organ weights and sex hormone serum levels. Yifuning significantly increased the levels of superoxide dismutase, glutathione peroxidase, catalase and reduced malondialdehyde and hydrogen peroxide levels. Yifuning reduced DNA damage in the ovaries by reducing the expression of 8‑OHDG and p53. Treatment with Yifuning significantly reduced the age‑induced p19, p53, p21 and Rb activity in the ovaries. The present study demonstrates that Yifuning prevents ovarian failure and the mechanism involved is partly associated with antioxidants and suppression of the Rb/p53 signal transduction pathway.
基金:
Natural Science Foundation of China (grant no. 81001701), Pearl River S&T Nova Program of Guangzhou Science & Technology Project (grant no. 2013J2200030), China Postdoctoral Science Foundation Funded Project (grant no. 2013T60965) to Dr Lei Liang and grants from Guangdong Provincial Administration of Traditional Chinese Medicine (grant no. 2010230 to Professor Zhi-Jian Guo).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2015]版:
大类|4 区医学
小类|4 区医学:研究与实验4 区肿瘤学
最新[2025]版:
大类|4 区医学
小类|4 区医学:研究与实验4 区肿瘤学
第一作者:
第一作者机构:[1]Department of Pharmacy, Guangzhou General Hospital of Guangzhou Military Command,Guangzhou, Guangdong 510010
共同第一作者:
通讯作者:
通讯机构:[1]Department of Pharmacy, Guangzhou General Hospital of Guangzhou Military Command,Guangzhou, Guangdong 510010[*1]Department of Pharmacy, Guangzhou General Hospital of Guangzhou Military Command, 111 Liuhua Road, Guangzhou, Guangdong 510010, P.R. China
推荐引用方式(GB/T 7714):
Liang Lei,Zhang Xu-Hui,Ji Bo,et al.Yifuning postpones ovarian aging through antioxidant mechanisms and suppression of the Rb/p53 signal transduction pathway.[J].Molecular medicine reports.2016,14(1):888-96.doi:10.3892/mmr.2016.5322.
APA:
Liang Lei,Zhang Xu-Hui,Ji Bo,Yao Hui,Ling Xiao-Mei...&Wu Xin-Rong.(2016).Yifuning postpones ovarian aging through antioxidant mechanisms and suppression of the Rb/p53 signal transduction pathway..Molecular medicine reports,14,(1)
MLA:
Liang Lei,et al."Yifuning postpones ovarian aging through antioxidant mechanisms and suppression of the Rb/p53 signal transduction pathway.".Molecular medicine reports 14..1(2016):888-96